EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Cancer clinical trial participation: a qualitative study of Black/African American communities’ and patient/survivors’ recommendations

Linda Kaljee, Sylvester Antwi iD, Doreen Dankerlui iD, Donna Harris iD, Barbara Israel, Denise White-Perkins iD, Valerie Ofori Aboah, Livingstone Aduse-Poku iD, Harriet Larrious-Lartey, Barbara Brush, Chris Coombe iD, La'Toshia Patman und 8 weitere

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkae119 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Linda Kaljee und 19 weiteren Autor:innen. Beteiligte Einrichtung: Henry Ford Health, Global Health Initiative, Detroit, MI 48202, United States. Hauptthemen laut MEDLINE: Black or African American, Clinical Trials as Topic, Neoplasms, Patient Participation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Black/African Americans experience disproportionate cancer burden and mortality rates. Racial and ethnic variation in cancer burden reflects systemic and health-care inequities, cancer risk factors, and heredity and genomic diversity. Multiple systemic, sociocultural, economic, and individual factors also contribute to disproportionately low Black/African American participation in cancer clinical trials.

Methods

The Participatory Action for Access to Clinical Trials project used a community-based participatory research approach inclusive of Black/African American community-based organizations, Henry Ford Health, and the University of Michigan Urban Research Center. The project aims were to understand Black/African Americans’ behavioral intentions to participate in cancer clinical trials and to obtain recommendations for improving participation. Audio-recorded focus group data were transcribed and coded, and searches were conducted to identify themes and subthemes. Representative text was extracted from the transcripts.

Results

Six community focus group discussions (70 participants) and 6 Henry Ford Health patient/survivor focus group discussions (29 participants) were completed. General themes related to trial participation were identified, including (1) systemic issues related to racism, health disparities, and trust in government, health systems, and clinical research; (2) firsthand experiences with health care and health systems; (3) perceived and experienced advantages and disadvantages of clinical trial participation; and (4) recruitment procedures and personal decision-making processes. Specific recommendations on how to address barriers were obtained.

Conclusions

Community-based participatory research is effective in bringing communities equitably to the table. To build trust, health systems must provide opportunities for patients and communities to jointly identify factors affecting cancer clinical trial participation, implement recommendations, and address health disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanClinical Trials as TopicNeoplasmsPatient ParticipationHumansFocus GroupsCommunity-Based Participatory ResearchMaleQualitative ResearchFemaleMiddle AgedAdultTrustHealthcare DisparitiesRacismAgedMichiganPatient SelectionHealth Status Disparities

Autor:innen und Institutionen

  • Henry Ford Health, Global Health Initiative, Detroit, MI 48202, United States.
  • Henry Ford Health, Detroit, MI 48202, United States.
  • Grace Learning Center, Detroit, MI 48228, United States.
  • University of Michigan Detroit Urban Research Center, Ann Arbor, MI 48109, United States.
  • Department of Family Medicine, Henry Ford Health, Detroit, MI 49224, United States.
  • University of Florida, Gainesville, FL 32611, United States.

ORCID-Profile: Sylvester Antwi, Doreen Dankerlui, Donna Harris, Denise White-Perkins, Livingstone Aduse-Poku, Chris Coombe, Nayomi Cawthorne, Zachary Rowe, Cassandra Mills, Kurt Fernando, Evelyn Jiagge

Förderung

  • Genentech

Zitieren

APA

Kaljee, L., Antwi, S., Dankerlui, D., Harris, D., Israel, B., White-Perkins, D., Ofori Aboah, V., Aduse-Poku, L., Larrious-Lartey, H., Brush, B., Coombe, C., Patman, L., Cawthorne, N., Chue, S., Rowe, Z., Mills, C., Fernando, K., Daniels, G., Walker, E. M., & Jiagge, E. (2025). Cancer clinical trial participation: a qualitative study of Black/African American communities’ and patient/survivors’ recommendations. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae119

Vancouver

Kaljee L, Antwi S, Dankerlui D, Harris D, Israel B, White-Perkins D, et al. Cancer clinical trial participation: a qualitative study of Black/African American communities’ and patient/survivors’ recommendations. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkae119

BibTeX
@article{Kaljee2025,
  author = {Kaljee, Linda and Antwi, Sylvester and Dankerlui, Doreen and Harris, Donna and Israel, Barbara and White-Perkins, Denise and Ofori Aboah, Valerie and Aduse-Poku, Livingstone and Larrious-Lartey, Harriet and Brush, Barbara and Coombe, Chris and Patman, La'Toshia and Cawthorne, Nayomi and Chue, Sophia and Rowe, Zachary and Mills, Cassandra and Fernando, Kurt and Daniels, Gwendolyn and Walker, Eleanor M and Jiagge, Evelyn},
  title = {Cancer clinical trial participation: a qualitative study of Black/African American communities’ and patient/survivors’ recommendations},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkae119}
}
Kostenlos starten →